← Leaderboards
Atul Chopra
Baylor College Of Medicine
$5,679,818
Attributed
$6,822,975
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,822,975 · 4
By mechanism
R01$6,062,471 · 3
K08$760,504 · 1
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Ashok Balasubramanyam$21,769,207
- Lawrence Chan$23,286,228
- Sang Jun Han$1,891,239
- Jennifer Orlet Fisher$5,388,264
- Kevin John Phillips$2,298,250
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityGeneticMutationThinnessIn VivoLaboratoriesMetabolic SyndromeWiedemann-Rautenstrauch SyndromeAdipose TissueHepaticObesity TreatmentFastingHormonesPlasmaBody WeightDesire For FoodAppetite StimulantsMediatingGlucose ProductionDiabetes MellitusMolecularNovel TherapeuticsGamma-Aminobutyric AcidAntibodies
Grant awards (18)
The CNS Receptor For Asprosin$553,467
R01 · FY2025 · DK · contact PI
The CNS Receptor For Asprosin$531,328
R01 · FY2024 · DK · contact PI
The CNS Receptor For Asprosin$553,467
R01 · FY2023 · DK · contact PI
The CNS Receptor For Asprosin$570,005
R01 · FY2022 · DK · contact PI
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and women$415,708
R01 · FY2022 · DK
ASPROSIN NEUTRALIZATION AS A NOVEL ANTI-OBESITY TREATMENT$408,044
R01 · FY2022 · DK · contact PI
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and women$682,457
R01 · FY2021 · DK
ASPROSIN NEUTRALIZATION AS A NOVEL ANTI-OBESITY TREATMENT$408,044
R01 · FY2021 · DK · contact PI
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and women$720,497
R01 · FY2020 · DK
ASPROSIN NEUTRALIZATION AS A NOVEL ANTI-OBESITY TREATMENT$408,044
R01 · FY2020 · DK · contact PI
ASPROSIN NEUTRALIZATION AS A NOVEL ANTI-OBESITY TREATMENT$402,895
R01 · FY2019 · DK · contact PI
ASPROSIN NEUTRALIZATION AS A NOVEL ANTI-OBESITY TREATMENT$408,515
R01 · FY2018 · DK · contact PI
The Role of FBN1 in mammalian energy balance$138,206
K08 · FY2018 · DK · contact PI
The Role of FBN1 in mammalian energy balance$19,557
K08 · FY2018 · DK · contact PI
The Role of FBN1 in mammalian energy balance$157,763
K08 · FY2017 · DK · contact PI
The Role of FBN1 in mammalian energy balance$148,326
K08 · FY2016 · DK · contact PI
The Role of FBN1 in mammalian energy balance$148,326
K08 · FY2015 · DK · contact PI
The Role of FBN1 in mammalian energy balance$148,326
K08 · FY2014 · DK · contact PI